{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T04:10:13Z","timestamp":1767499813380,"version":"3.45.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,10]]},"abstract":"<jats:p>Epidemiological and clinical studies have indicated a higher risk of nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM), implying a potentially shared genetic etiology, which is still less explored. Genetic links between T2DM and NAFLD were assessed using linkage disequilibrium score regression and pleiotropic analysis under composite null hypothesis. European GWAS data have identified shared genes, whereas SNP-level pleiotropic analysis under composite null hypothesis has explored pleiotropic loci. generalized gene-set analysis of GWAS data determines pleiotropic pathways and tissue enrichment using eQTL mapping to identify associated genes. Mendelian randomization analysis was used to investigate the causal relationship between NAFLD and T2DM. Linkage disequilibrium score regression analysis revealed a strong genetic correlation between T2DM and NAFLD, and identified 24 pleiotropic loci. These single-nucleotide polymorphisms are primarily involved in biosynthetic regulation, RNA biosynthesis, and pancreatic development. generalized gene-set analysis of GWAS data analysis revealed significant enrichment in multiple brain tissues. Gene mapping using these 3 methods led to the identification of numerous pleiotropic genes, with differences observed in liver and kidney tissues. These genes were mainly enriched in pancreas, brain, and liver tissues. The Mendelian randomization method indicated a significantly positive unidirectional causal relationship between T2DM and NAFLD. Our study identified a shared genetic structure between NAFLD and T2DM, providing new insights into the genetic pathogenesis and mechanisms of NAFLD and T2DM comorbidities.<\/jats:p>","DOI":"10.1097\/md.0000000000038008","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T14:05:53Z","timestamp":1715349953000},"page":"e38008","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Exploring the interconnected between type 2 diabetes mellitus and nonalcoholic fatty liver disease: Genetic correlation and Mendelian randomization analysis"],"prefix":"10.1097","volume":"103","author":[{"given":"Wenjuan","family":"Ni","sequence":"first","affiliation":[{"name":"Department of Endocrinology, First Affiliated Hospital of Baotou Medical Collage, Baotou, Inner Mongolia, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Lu","sequence":"additional","affiliation":[{"name":"Baotou Medical Collage, Baotou, Inner Mongolia, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, First Affiliated Hospital of Baotou Medical Collage, Baotou, Inner Mongolia, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20251125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S2213-8587(20)30022-X","article-title":"Inadequate beta-cell mass is essential for the pathogenesis of type 2 diabetes.","volume":"8","author":"Weir","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R2-20251125","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(22)01655-5","article-title":"Type 2 diabetes.","volume":"400","author":"Ahmad","year":"2022","journal-title":"Lancet"},{"key":"R3-20251125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes.","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R4-20251125","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","article-title":"A position statement on NAFLD\/NASH based on the EASL 2009 special conference.","volume":"53","author":"Ratziu","year":"2010","journal-title":"J Hepatol"},{"key":"R5-20251125","doi-asserted-by":"crossref","first-page":"e0124749","DOI":"10.1371\/journal.pone.0124749","article-title":"Association between the fatty liver index and risk of type 2 diabetes in the EPIC-Potsdam study.","volume":"10","author":"Jager","year":"2015","journal-title":"PLoS One"},{"key":"R6-20251125","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.metabol.2016.01.001","article-title":"Non-alcoholic fatty liver disease and diabetes.","volume":"65","author":"Hazlehurst","year":"2016","journal-title":"Metabolism"},{"key":"R7-20251125","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease.","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"R8-20251125","doi-asserted-by":"crossref","first-page":"2931985","DOI":"10.1155\/2016\/2931985","article-title":"The burden of NAFLD and its characteristics in a nationwide population with type 2 diabetes.","volume":"2016","author":"Forlani","year":"2016","journal-title":"J Diabetes Res"},{"key":"R9-20251125","doi-asserted-by":"crossref","first-page":"755","DOI":"10.31083\/j.rcm2203082","article-title":"Pathophysiological mechanisms and clinical evidence of relationship between nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease.","volume":"22","author":"Galiero","year":"2021","journal-title":"Rev Cardiovasc Med"},{"key":"R10-20251125","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/antiox10020270","article-title":"Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. a narrative review.","volume":"10","author":"Rinaldi","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"R11-20251125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cld.2007.02.002","article-title":"Pathologic assessment of non-alcoholic fatty liver disease.","volume":"11","author":"Bondini","year":"2007","journal-title":"Clin Liver Dis"},{"key":"R12-20251125","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2337\/dc07-0349","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients.","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"R13-20251125","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1478-3231.2011.02482.x","article-title":"Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.","volume":"31","author":"Leite","year":"2011","journal-title":"Liver Int"},{"key":"R14-20251125","doi-asserted-by":"crossref","first-page":"6638306","DOI":"10.1155\/2020\/6638306","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes mellitus: a bidirectional relationship.","volume":"2020","author":"Muzica","year":"2020","journal-title":"Can J Gastroenterol Hepatol"},{"key":"R15-20251125","doi-asserted-by":"crossref","first-page":"3920196","DOI":"10.1155\/2020\/3920196","article-title":"The intricate relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD).","volume":"2020","author":"Tanase","year":"2020","journal-title":"J Diabetes Res"},{"key":"R16-20251125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00228-023-03586-1","article-title":"The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review.","volume":"80","author":"Zachou","year":"2024","journal-title":"Eur J Clin Pharmacol"},{"key":"R17-20251125","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13059-021-02478-w","article-title":"SUPERGNOVA: local genetic correlation analysis reveals heterogeneous etiologic sharing of complex traits.","volume":"22","author":"Zhang","year":"2021","journal-title":"Genome Biol"},{"key":"R18-20251125","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ng.3406","article-title":"An atlas of genetic correlations across human diseases and traits.","volume":"47","author":"Bulik-Sullivan","year":"2015","journal-title":"Nat Genet"},{"key":"R19-20251125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation.","volume":"526","author":"Genomes Project","year":"2015","journal-title":"Nature"},{"key":"R20-20251125","doi-asserted-by":"crossref","first-page":"e1009218","DOI":"10.1371\/journal.pgen.1009218","article-title":"A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between type 2 diabetes and prostate cancer.","volume":"16","author":"Ray","year":"2020","journal-title":"PLoS Genet"},{"key":"R21-20251125","doi-asserted-by":"crossref","first-page":"e1004219","DOI":"10.1371\/journal.pcbi.1004219","article-title":"MAGMA: generalized gene-set analysis of GWAS data.","volume":"11","author":"de Leeuw","year":"2015","journal-title":"PLoS Comput Biol"},{"key":"R22-20251125","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/s41467-017-01261-5","article-title":"Functional mapping and annotation of genetic associations with FUMA.","volume":"8","author":"Watanabe","year":"2017","journal-title":"Nat Commun"},{"key":"R23-20251125","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"R24-20251125","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses.","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"R25-20251125","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies.","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R26-20251125","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V","article-title":"Explaining heterogeneity in meta-analysis: a comparison of methods.","volume":"18","author":"Thompson","year":"1999","journal-title":"Stat Med"},{"key":"R27-20251125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R28-20251125","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/ije\/dyx034","article-title":"MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data.","volume":"46","author":"Yavorska","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R29-20251125","doi-asserted-by":"crossref","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"R30-20251125","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"R31-20251125","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3390\/biomedicines11041097","article-title":"Non-alcoholic fatty liver disease or type 2 diabetes mellitus-the chicken or the egg dilemma.","volume":"11","author":"Kosmalski","year":"2023","journal-title":"Biomedicines"},{"key":"R32-20251125","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/hmg\/ddw400","article-title":"MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat.","volume":"26","author":"Musso","year":"2017","journal-title":"Hum Mol Genet"},{"key":"R33-20251125","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s11892-015-0607-4","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms.","volume":"15","author":"Saponaro","year":"2015","journal-title":"Curr Diab Rep"},{"key":"R37-20251125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus.","volume":"14","author":"Tilg","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R38-20251125","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R39-20251125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1210\/er.2012-1009","article-title":"Diabetes and nonalcoholic fatty liver disease: a pathogenic duo.","volume":"34","author":"Williams","year":"2013","journal-title":"Endocr Rev"},{"key":"R40-20251125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2337\/dc19-1113","article-title":"Economic and clinical burden of nonalcoholic steatohepatitis in patients with type 2 diabetes in the U.S.","volume":"43","author":"Younossi","year":"2020","journal-title":"Diabetes Care"},{"key":"R41-20251125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement.","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R42-20251125","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/hep.28972","article-title":"Growth factor receptor binding protein 14 inhibition triggers insulin-induced mouse hepatocyte proliferation and is associated with hepatocellular carcinoma.","volume":"65","author":"Morzyglod","year":"2017","journal-title":"Hepatology"},{"key":"R43-20251125","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1038\/s41598-020-60290-1","article-title":"Inhibition of Grb14, a negative modulator of insulin signaling, improves glucose homeostasis without causing cardiac dysfunction.","volume":"10","author":"Ding","year":"2020","journal-title":"Sci Rep"},{"key":"R44-20251125","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/hep.31771","article-title":"Liver-specific deletion of mouse Tm6sf2 promotes steatosis, fibrosis, and hepatocellular cancer.","volume":"74","author":"Newberry","year":"2021","journal-title":"Hepatology"},{"key":"R45-20251125","doi-asserted-by":"crossref","first-page":"102003","DOI":"10.1016\/j.clinre.2022.102003","article-title":"NAFLD: genetics and its clinical implications.","volume":"46","author":"Sharma","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R46-20251125","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.numecd.2023.06.004","article-title":"Effects of TM6SF2 rs58542926 polymorphism on hepatocellular lipids and insulin resistance in early type 2 diabetes.","volume":"33","author":"Bodis","year":"2023","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R47-20251125","doi-asserted-by":"crossref","first-page":"e00179","DOI":"10.1002\/edm2.179","article-title":"Human and molecular genetics shed lights on fatty liver disease and diabetes conundrum.","volume":"3","author":"Tavaglione","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"key":"R48-20251125","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3390\/pharmaceutics14020354","article-title":"Pharmacogene variants associated with liver transplant in a twelve-year clinical follow-up.","volume":"14","author":"Sendra","year":"2022","journal-title":"Pharmaceutics"},{"key":"R49-20251125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13318-022-00802-8","article-title":"Hepatic transporters alternations associated with Non-alcoholic Fatty Liver Disease (NAFLD): a systematic review.","volume":"48","author":"Omidkhoda","year":"2023","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"R50-20251125","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1007\/s12035-023-03210-4","article-title":"High-fat diet feeding triggers a regenerative response in the adult zebrafish brain.","volume":"60","author":"Azbazdar","year":"2023","journal-title":"Mol Neurobiol"},{"key":"R51-20251125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.biochi.2022.01.001","article-title":"Diabetes mellitus and melatonin: where are we?","volume":"202","author":"Patel","year":"2022","journal-title":"Biochimie"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:01:24Z","timestamp":1764072084000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":48,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038008","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,5,10]]}}}